Yield10 Bioscience
YTEN
Operating Margin for Yield10 Bioscience (YTEN)
Operating Margin as of May 2024 (TTM): -2,980.00%
According to Yield10 Bioscience's latest financial reports and stock price the company's current Operating Margin is -2,980.00%. At the end of 2021 the company had an Operating Margin of -1,790.72%.
Operating Margin history for Yield10 Bioscience from 2004 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,790.72% | 40.96% |
| 2020 | -1,270.34% | -22.49% |
| 2019 | -1,638.96% | -0.63% |
| 2018 | -1,649.28% | 65.7% |
| 2017 | -995.34% | 12.15% |
| 2016 | -887.49% | -2.79% |
| 2015 | -912.91% | -4.51% |
| 2014 | -956.00% | 69.04% |
| 2013 | -565.55% | -6692.84% |
| 2012 | 8.58% | -100.31% |
| 2011 | -2,727.09% | -68.62% |
| 2010 | -8,691.74% | 219.81% |
| 2009 | -2,717.82% | 8.67% |
| 2008 | -2,501.09% | 24.48% |
| 2007 | -2,009.27% | 426.28% |
| 2006 | -381.79% | 51.15% |
| 2005 | -252.59% | 85.81% |
| 2004 | -135.94% | -235.94% |
| 2003 | 100.00% | -139.28% |
| 2002 | -254.60% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -234,760.00% | 7,777.85% | Bahamas |
 NRC Health
NRC | 32.86% | -101.10% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.